BRCK Group Acquires Premium Fencing Specialist H.S. Jackson & Son for £15m
BRCK Group acquires premium fencing specialist Jacksons in a £15m deal with performance-linked deferred consideration – a shareholder-friendly, diversified play on infrastructure.
This article covers information on Brickability Group PLC.
LON:BRCKBRCK Group’s Jacksons acquisition explained: what the £15.0 million fencing deal actually means
BRCK Group has agreed to buy H.S. Jackson & Son (Fencing) Limited, known as Jacksons, in a deal that adds a premium fencing, gates and perimeter security business to the group. The headline figure is an initial consideration of £15.0 million, with a further £4.9 million for Jacksons’ freehold land and property, both payable on completion.
There is also deferred consideration of up to £11 million, but that part is contingent on hitting financial performance targets over the three years after completion. In plain English, BRCK is paying a solid amount up front, with the option to pay more only if Jacksons performs well.
For retail investors, that structure matters. It reduces some of the risk of overpaying while giving the seller a reason to keep pushing growth after the deal completes.
Key BRCK-Jacksons acquisition numbers retail investors should know
| Item | Figure |
|---|---|
| Initial consideration | £15.0 million |
| Property consideration | £4.9 million |
| Maximum deferred consideration | Up to £11.0 million |
| Cash paid on completion for initial consideration | £14.5 million |
| Consideration shares issued | 1,024,414 new ordinary shares |
| Jacksons revenue for year ended 30 September 2025 (unaudited) | Approximately £40.9 million |
| Jacksons EBITDA for year ended 30 September 2025 (unaudited) | Approximately £4.2 million |
| Jacksons net assets at 30 September 2025 | Approximately £26.1 million |
| Expected completion date | On or around 30 June 2026 |
EBITDA means earnings before interest, tax, depreciation and amortisation. It is a common profit measure used in acquisitions because it gives a cleaner view of the operating business before financing and accounting charges.
Why BRCK wants Jacksons: premium fencing, infrastructure exposure and broader product range
This is not a random bolt-on. BRCK says the acquisition is part of its diversification strategy, and Jacksons fits that neatly.
Jacksons designs, manufactures and installs premium timber and steel fencing, gates and perimeter security systems. That gives BRCK exposure to a broader slice of the construction and infrastructure market, including residential, commercial, industrial and high-security end markets.
The most interesting part of the RNS is probably the customer mix. Jacksons serves critical national infrastructure, schools and other government-backed projects, alongside premium residential and commercial perimeter fencing. That matters because those markets can be more resilient than some standard construction categories, particularly when public-sector or infrastructure spending holds up better than private building activity.
There is also a quality angle here. Jacksons’ timber fencing comes with a 25-year guarantee against rot and insect attack through its proprietary Jakcure process, while its steel fencing carries a 25-year service life guarantee. Premium products, long warranties and specialist applications usually point to stronger margins than commoditised building materials.
Is BRCK paying a sensible price for Jacksons?
On the figures disclosed, the upfront deal does not look stretched. The initial consideration of £15.0 million is about 3.6 times Jacksons’ approximately £4.2 million EBITDA for the year ended 30 September 2025.
If you include the £4.9 million property consideration, the upfront total rises to £19.9 million, which is roughly 4.7 times EBITDA. That still looks pretty reasonable for a premium, established manufacturing and installation business with freehold property and exposure to infrastructure projects.
The full price could rise further because of the deferred consideration of up to £11.0 million. If the maximum were paid, total consideration would reach £30.9 million. That would only happen if Jacksons hits the agreed performance targets, so BRCK is effectively saying: we will pay more if the business delivers more.
That is a positive structure from a shareholder perspective. It helps align the price with future performance rather than handing over the whole lot on day one.
Funding, dilution and balance sheet impact at BRCK
Another positive is funding. BRCK says the cash consideration and property consideration will be funded from existing Company resources. In other words, there is no new fundraise announced here, and no mention of taking on fresh acquisition financing in this RNS.
That suggests BRCK had the firepower ready, which lines up with its description of having a strong balance sheet. Investors usually like that because it avoids the immediate pain of an emergency placing or a debt-heavy structure.
There is a small equity element. BRCK will issue 1,024,414 new shares worth £0.5 million as part of the initial consideration. After admission, the company will have 323,270,660 ordinary shares in issue, so the dilution looks modest at roughly 0.3%.
There is also a lock-in on those consideration shares. They are subject to a 24-month hard lock-in, followed by a 12-month orderly market arrangement. That reduces the risk of an immediate seller dump into the market, which is reassuring.
What BRCK shareholders should like – and what they should be careful about
Positives from the BRCK acquisition of H.S. Jackson & Son
- Earnings enhancing: BRCK expects the acquisition to be earnings enhancing in the first full year after completion. That means it should increase earnings, not dilute them.
- Diversification: BRCK expands beyond core construction materials distribution into specialist fencing, gates and perimeter security.
- Premium positioning: Jacksons has long warranties, proprietary processes and exposure to specialist projects, which can support margins.
- Broad customer base: Residential, commercial, industrial and government-backed projects lower dependence on one end market.
- Sensibly structured consideration: A chunk of the price is deferred and tied to performance.
Risks and watchpoints after the Jacksons deal completes
- Integration risk: Every acquisition sounds good on announcement day. Delivery is what counts.
- Deferred consideration could rise: Up to £11.0 million more may be payable if targets are met. That is fine if growth follows, but investors should still watch the economics.
- Limited detail on synergies: BRCK talks about growth opportunities and pipeline, but no cost synergies or quantified upside are disclosed.
- Unaudited financials: The £40.9 million revenue and £4.2 million EBITDA figures for Jacksons are unaudited.
What to watch next from BRCK Group after the Jacksons acquisition
The next milestone is completion, expected on or around 30 June 2026. Investors should also watch for any update on early trading, integration progress and whether management starts to quantify cross-selling or infrastructure-related opportunities.
It will also be worth tracking how Jacksons sits inside BRCK’s wider portfolio of specialist construction businesses. If BRCK can preserve the Jacksons brand and premium positioning while giving it broader reach, this could be one of those acquisitions that looks obvious in hindsight.
My take on the BRCK Group Jacksons deal
This looks like a good, sensible acquisition rather than a flashy one. BRCK is buying a long-established business founded in 1947, with premium products, freehold property, broad end markets and useful exposure to major government infrastructure work.
The price looks disciplined on the numbers disclosed, the dilution is tiny, and the funding does not appear stretched. The main caveat is simple: management now needs to prove that “diversification strategy” turns into real earnings growth and not just a larger group chart in the annual report.
Based on this RNS alone, I would view the announcement as positive. It adds quality, broadens BRCK’s offering and seems structured in a shareholder-friendly way.
Related
Keep reading
Investing
AstraZeneca’s Enhertu delivers Phase III lung cancer PFS win
Enhertu delayed disease progression versus standard care in a Phase III lung cancer trial, supporting its potential move into first-line treatment.
JoshuaAugust 17, 2026
Investing
Optima Health FY26 results: growth beats expectations as PAM integration begins
Optima Health beat adjusted EBITDA expectations in FY26, while the £100 million PAM acquisition reshaped its growth prospects and balance sheet.
JoshuaAugust 17, 2026
Investing
Nostrum Oil & Gas Agrees $304.6 Million Kazakhstan Sale Ahead of Wind-Down
Nostrum plans to sell its Kazakhstan operations, repay secured notes in full and begin an orderly wind-down after completion.
JoshuaAugust 17, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.